Literature DB >> 10487397

Drug-induced nail disorders: incidence, management and prognosis.

B M Piraccini1, A Tosti.   

Abstract

A large number of drugs of different classes, ranging from antibacterials to chemotherapeutic agents to psoralens, can be responsible for the development of nail changes. Drug-induced nail changes usually involve several or all 20 nails and appear in temporal correlation with drug intake. Some nail changes are asymptomatic and only cause cosmetic problems, while others cause pain and discomfort and impair manual activities or deambulation. Drug-induced nail abnormalities are usually transitory and disappear with drug withdrawal, but sometimes persist in time. The pathogenesis of the nail changes is usually a toxic effect of the drug on the different nail constituents, but other mechanisms can be involved. Drugs that are well known to produce nail abnormalities include cancer chemotherapeutic agents, psoralens, retinoids, tetracyclines, antimalarials and zidovudine. Arsenic poisoning is also always associated with nail changes that have medico-legal importance. Some drugs taken during pregnancy may impair nail development of the fetus, and nail hypoplasia or other nail dystrophies will be evident in the newborn.

Entities:  

Mesh:

Year:  1999        PMID: 10487397     DOI: 10.2165/00002018-199921030-00004

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  41 in total

Review 1.  Nail changes secondary to environmental influences.

Authors:  R G Positano; T M DeLauro; B J Berkowitz
Journal:  Clin Podiatr Med Surg       Date:  1989-04       Impact factor: 1.231

2.  Fixed-drug eruption presenting as an acute paronychia.

Authors:  R Baran; C Perrin
Journal:  Br J Dermatol       Date:  1991-12       Impact factor: 9.302

3.  Paronychia and pyogenic granuloma of the great toes in patients treated with indinavir.

Authors:  F Bouscarat; C Bouchard; D Bouhour
Journal:  N Engl J Med       Date:  1998-06-11       Impact factor: 91.245

4.  Photo-onycholysis induced by 8-methoxypsoralen.

Authors:  L Zala; A Omar; A Krebs
Journal:  Dermatologica       Date:  1977

5.  Fetal growth, major malformations, and minor anomalies in infants born to women receiving valproic acid.

Authors:  E Jäger-Roman; A Deichl; S Jakob; A M Hartmann; S Koch; D Rating; R Steldinger; H Nau; H Helge
Journal:  J Pediatr       Date:  1986-06       Impact factor: 4.406

6.  Letter: Side benefits of the pill.

Authors:  J F Knight
Journal:  Med J Aust       Date:  1974-11-02       Impact factor: 7.738

7.  Acute bullous dermatosis and onycholysis due to high-dose methotrexate and leucovorin calcium.

Authors:  J C Chang
Journal:  Arch Dermatol       Date:  1987-08

8.  Acquired nail beading in patients receiving itraconazole--an indicator of faster nail growth? A study using optical profilometry.

Authors:  P D Doncker; G E Pierard
Journal:  Clin Exp Dermatol       Date:  1994-09       Impact factor: 3.470

Review 9.  Transverse leukonychia in patients receiving cancer chemotherapy.

Authors:  S Chapman; P R Cohen
Journal:  South Med J       Date:  1997-04       Impact factor: 0.954

10.  Yellow lunulae with fluorescence after tetracycline therapy.

Authors:  A A Hendricks
Journal:  Arch Dermatol       Date:  1980-04
View more
  14 in total

Review 1.  Indinavir-induced retinoid-like effects: incidence, clinical features and management.

Authors:  Jesús García-Silva; Manuel Almagro; Carmen Peña-Penabad; Eduardo Fonseca
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

Review 2.  Pharmacokinetics of antifungal agents in onychomycoses.

Authors:  D Debruyne; A Coquerel
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

3.  Cyclophosphamide and Doxorubicin Induced Melanonychia: A Case Report.

Authors:  Vivek Bhanubhai Prajapati; Sharath Madhyastha; Raviraj Acharya; Vinaya Gopalaswamy; Akhila Doddamani
Journal:  J Clin Diagn Res       Date:  2017-01-01

4.  A randomized phase 2 trial of the efficacy and safety of a novel topical povidone-iodine formulation for Cancer therapy-associated Paronychia.

Authors:  Kara D Capriotti; Milan Anadkat; Jennifer Choi; Benjamin Kaffenberger; Beth McLellan; Samuel Barone; Oluwaseun Kukoyi; Shari Goldfarb; Mario Lacouture
Journal:  Invest New Drugs       Date:  2019-06-26       Impact factor: 3.850

Review 5.  Drug-induced skin, nail and hair disorders.

Authors:  Laurence Valeyrie-Allanore; Bruno Sassolas; Jean-Claude Roujeau
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

6.  Diclofenac-Induced Photo-Onycholysis.

Authors:  Lutfi Al-Kathiri; Abla Al-Asmaili
Journal:  Oman Med J       Date:  2016-01

7.  The Effect of Nail Lacquer on Taxane-Induced Nail Changes in Women With Breast Cancer.

Authors:  Osama Alshari; Abdelwahab Aleshawi; Ahmed H Al Sharie; Ala'a Msameh; Isra Al-Omari; Renad Msameh; Abdallah Almegdadi; Dima Albals
Journal:  Breast Cancer (Auckl)       Date:  2020-06-15

8.  Melanonychia.

Authors:  Julie Jefferson; Phoebe Rich
Journal:  Dermatol Res Pract       Date:  2012-06-27

9.  Chromonychia secondary to chemotherapy.

Authors:  Marien Lopes; Clarice Jordão; Rachel Grynszpan; Celso Sodré; Marcia Ramos-E-Silva
Journal:  Case Rep Dermatol       Date:  2013-06-06

10.  Zidovudine-induced nail hyper-pigmentation in 45-year-old women prescribed for HIV/tuberculosis co-infection.

Authors:  Vishal R Tandon; Shamiya Sadiq; Vijay Khajuria; Annil Mahajan; Sudhaa Sharma; Zahid Gillani
Journal:  J Midlife Health       Date:  2016 Jan-Mar
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.